
|Articles|January 26, 2004
New drug is first to be OK'd for bipolar depression
Clinicians can now treat patients with bipolar depression using the first drug approved in the U.S. for this indication. The FDA recently approved olanzapine/fluoxetine (Symbyax, Eli Lilly) for the treatment of depressive episodes associated with bipolar disorder. Symbyax is currently available in pharmacies.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Targeted Coordination Is Crucial in Boosting Pneumococcal Vaccine Coverage
2
Pharmacists Can Reduce HIV Stigma, Increase Access to Care
3
OTC: Most-Read Stories of 2025
4
The Providers, Representation Needed to Normalize HIV Care, Prevention
5














































































































